At a glance
The October 19, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on COVID-19 test reporting tool, effects of increased SARS-CoV-2 testing, ÐÇ¿ÕÓéÀÖ¹ÙÍø's use of COVID-19 testing data, and an FDA update.
Agenda
Welcome: Jasmine Chaitram, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Laboratory Systems (DLS)
National Healthcare Safety Network (NHSN) Point-of-Care Test Reporting Tool for COVID-19 in Long-Term Care Facilities: Kathy Bridson, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Healthcare Quality Promotion (DHQP)
2020-2021 Influenza Testing Issues: Tim Uyeki, ÐÇ¿ÕÓéÀÖ¹ÙÍø Influenza Division (ID)
Effects of Increased SARS-CoV-2 Testing on Laboratory Services: An Emerging Infections Network (EIN) Survey: Dan Diekema, University of Iowa
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)
How Does ÐÇ¿ÕÓéÀÖ¹ÙÍø Use COVID-19 Laboratory Testing Data?: Jason Hall, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Preparedness and Emerging Infections (DPEI) and Ed Lockhart, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Laboratory Systems (DLS)